PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 10, 2026Journal for ImmunoTherapy of Cancer0 citationsOpen Access

Sensory neuron-derived CCL5 orchestrates an immunosuppressive niche via regulatory T cells to fuel head and neck tumor progression

View Full Paper
KWKailiu WuZZZhen ZhangXQXing Qin

Key Points

  • This research investigates the interaction between neural infiltration and immune modulation in oral squamous cell carcinoma (OSCC).
  • Utilized spatial transcriptomics and in vitro/in vivo experiments to study the effects of intratumoral nerves on Tregs.
  • Validated findings with clinical specimens.
  • Examined the impact of CCL5 and RAMP1 blockade on tumor progression.
  • Intratumoral nerves increase regulatory T cell recruitment via CCL5-mediated chemotaxis.
  • RAMP1 signaling activates an immunosuppressive Treg phenotype, assisting tumor progression.
  • Therapeutic combinations of CCL5 or RAMP1 blockade with anti-CTLA-4 or anti-PD-1 antibodies significantly enhance anti-tumor effects.

Abstract

Background Perineural invasion (PNI) is a hallmark of malignancy in solid tumors, including oral squamous cell carcinoma (OSCC), and is closely associated with poor prognosis. Emerging evidence suggests a critical association between PNI and the tumor immune microenvironment (TME). Methods In this study, we used spatial transcriptomics, in vitro and in vivo experiments, and clinical specimen validation to systematically study the interplay between neural infiltration and immune modulation in OSCC. Results Our results suggest that intratumoral nerves may enhance the recruitment of regulatory T cells (Tregs) through C-C motif chemokine ligand 5 (CCL5)-mediated chemotaxis and further promote the acquisition of an immunosuppressive phenotype in Tregs by activating the RAMP1 signaling pathway. Through these coordinated mechanisms, neural components in the TME contribute to immune suppression and facilitate tumor progression. Therapeutically, both combination of CCL5 blockade with anti-CTLA-4 antibody and the combination of RAMP1 blockade with anti-PD-1 antibody exhibited significantly enhanced anti-tumor efficacy. Conclusions This study highlights a previously underappreciated neural-Treg axis in the TME and provides new insights into potential combinatorial strategies for cancer immunotherapy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wu et al. (2026) studied this question.

synapsesocial.com/papers/6a0020cec8f74e3340f9b992https://doi.org/10.1136/jitc-2025-013958
Ask AI
Helpful
Bookmark
Share
View Full Paper